Mamegel, Magno .
HRN: 23-93-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/08/2024
10/14/2024
IVT
2.25g
Q24
CAP-HR
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes